Understanding supplements.
How do I evaluate what you're actually buying — in the aisle built on a null trial?
The joint aisle is the supplement industry's oldest territory and its most instructive failure: the category's best-selling ingredients for two decades — glucosamine and chondroitin — were tested in a 1,583-patient NIH trial and returned the field's honest zero, yet the bottles never left the shelves. The honest aisle is narrow and form-dependent: an absorption-engineered curcumin (the form IS the dose), a 40 mg undenatured collagen signal (the word 'undenatured' IS the product), and an anthocyanin-standardized cherry capsule (fructose-free, deliberately). Everything else on the joint shelf — the complexes, the bone broths, the 'cartilage rebuilders' — sells a result that does not exist: no supplement has ever demonstrated cartilage regrowth, because the OA disease-modifying drug itself does not yet exist.
Curcumin Phytosome
The absorption-engineered form
UC-II Capsules
40 mg undenatured — the signal dose
Cherry Capsules
Anthocyanins without the juice's sugar
'Joint Health Complexes'
The GAIT-nulled kitchen sinks
UC-II — Undenatured (40 mg)
The native triple-helix structure preserved — a signal dose for oral immune tolerance, not a material dose. The label word 'UNDENATURED' is the product: hydrolyzed type II collagen is a different substance at a different dose for a different purpose. Poultry-derived.
Hydrolyzed Peptides (10–20 g) — and the Nulls
The hydrolyzed powders are our skin page's products — grams of pre-cut material for the dermis's loom, a different mechanism entirely. And the legacy shelf — glucosamine + chondroitin — carries GAIT's honest zero: safe, best-selling, and no better than placebo overall. Three collagen-shelf stories, three different verdicts: the label's words are the entire map.
Choosing the Right Form & Dose
Label literacy in the joint aisle has four specific jobs:
- The curcumin absorption check: phytosome or an equivalent absorption strategy, stated — unformulated curcuminoids are the trial evidence's absence in a bottle.
- The 'undenatured' word: UC-II is native-structure type II at 40 mg; 'hydrolyzed type II collagen' is a different product at a different dose — the two are not interchangeable, and the honest label says which it is.
- The anthocyanin standardization: cherry products standardized to content, in capsule form — the fructose-free delivery the gout context requires.
- The GAIT-aware default: if a 'joint complex' leads with glucosamine and chondroitin, it leads with the nulled pair — safe, possibly placebo-tier, and never a reason to skip the exercise prescription that actually works.
- The standing rule: third-party verification (USP, NSF, ConsumerLab) — chondroitin's label-accuracy record is famously poor, and a category built on form and dose demands the label be true.
Red Flags to Watch For
The joint market sells to the pain population with the industry's oldest claims. Be highly cautious of products that:
- Promise to 'rebuild cartilage' or 'regrow joints' — no supplement has ever demonstrated it; the OA disease-modifying drug does not exist yet. The claim itself disqualifies the product.
- Market 'natural gout cures' as therapy replacement — treat-to-target urate therapy dissolves crystals and ends the disease; the shelf-substituted delay is the harm path gout guidelines warn about.
- Lead with the GAIT-nulled pair at premium pricing — the honest zero is free to accept, but expensive to buy.
- Sell 'collagen building block' gummies and bone-broth powders for joints — token doses of the material story, absent the signal dose (UC-II) or the skin-page's gram doses that at least match their own trials.
- Stack Boswellia, MSM, and '5-LOXIN' complexes at borrowed certainty — small trials sold at first-line confidence, the kitchen-sink formula this library retires in every aisle it meets.